| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.03 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |